July 8, 2021 12:42 PM EDT
Manufacturing

Re­call re­port: Teva's chemother­a­py drug re­called af­ter in­ves­ti­ga­tors find par­tic­u­lates in­side vials

Josh Sullivan

A chemother­a­py drug from Te­va Phar­ma­ceu­ti­cals has been vol­un­tar­i­ly re­called af­ter a com­plaint from a phar­ma­cy that par­tic­u­late was found in­side a glass vial. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times